ACUR

Acura Pharmaceuticals (CE) (ACUR)

Acura Pharmaceuticals Inc (CE)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:USOTC:ACUR

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/11/21	22:32	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/11/05	05:00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/10/03	00:16	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/08/10	03:44	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/07/27	04:52	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/06/05	00:00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/05/15	21:00	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/05/15	05:40	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/02/15	00:53	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/02/03	00:27	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/01/11	07:13	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/01/03	05:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/01/03	05:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/01/03	05:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2024/01/03	05:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/12/22	02:01	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/12/07	04:35	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/11/21	02:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/11/21	02:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/11/21	02:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/11/21	02:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/11/04	01:42	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/10/13	01:05	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/09/26	05:10	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/09/01	20:00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/09/01	05:10	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/08/31	05:10	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/08/17	00:20	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/08/11	01:17	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)
2023/07/29	05:41	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:ACUR	Acura Pharmaceuticals Inc (CE)